-
Electronic (PDF)
-
1 - 5 Users
-
1 - 10 Users
-
1 - 15 Users
Cosmetic Procedures and Products - Global Strategic Business Report
Global Industry Analysts, Inc, April 2012, Pages: 351
This report analyzes the US and the European markets for Cosmetic Procedures and Products in US$ Million. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The US market in the report is analyzed in terms of both Cosmetic Surgery Products and Cosmetic Procedures. The major product segments analyzed under the Cosmetic Surgery Products Category include - Equipment (Lasers, Microdermabrators, and Other Equipment), Injectables (Botulinum Toxin Type A, Dermal Fillers, and Other Injectables), Implants (Breast Implants, and Other Implants), and others.
Major segments covered under the Cosmetic Surgery Procedures Category include - Surgical Procedures (Breast Augmentation, Abdominoplasty, Blenpharoplasty, Facelift, Liposuction, Rhinoplasty, and Others) and Non-Surgical Procedures (Botox, Dermal Fillers, Laser Hair Removal, Laser Skin Resurfacing, Chemical Peel, Microdermabrasion, and Others). The European market is analyzed for only Cosmetic Procedures by the following product segments - Surgical Procedures (Breast Augmentation, Liposuction, Blepharoplasty, Rhinoplasty) and Non-Surgical Procedures.
The report profiles 78 companies including many key and niche players such as Allergan, Inc., Anika Therapeutics, Merz Aesthetics, Candela Corporation, Cutera Inc., Cynosure, Inc., DermaMed Solutions, Valeant Pharmaceuticals International, Inc., ExcellaDerm Corporation, Genesis Biosystems Inc., Johnson & Johnson, Mentor Corp., Lumenis Ltd., Medicis Pharmaceutical Corporation, Palomar Medical Technologies, Inc., Q-Med AB, Solta Medical, Inc., and Suneva Medical, Inc.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying.
COSMETIC PROCEDURES AND PRODUCTS
A US AND EUROPEAN MARKET REPORT
CONTENTS
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. A US AND EUROPEAN MARKET REPORT
1. THE UNITED STATES II-1
1a. INDUSTRY SCENARIO II-1
Recession Impact in Retrospect II-1
The Road Ahead! II-1
Injectables to Fuel Growth II-2
Implants to Continue Market Augmentation II-2
Equipment - Growth Slows, But Prospects Don't II-3
1b. MARKET DYNAMICS II-4
Botox for Early Use - The New Market Positioning II-4
Americans to Explore Overseas Options II-4
Table 1: A Comparison of Average Fee for Surgical Procedures
in the US Against Western and Eastern Europe II-4
Hyaluronic Acid Uses to Grow II-5
Lasers Demand Slows Amid Recession II-5
Reality TV Drives Demand, Creates Unrealistic Expectations II-5
Improving Awareness! II-5
Liposuction, the Non-invasive Way, Catches Eye II-6
Silicone Implants Rupture Saline Sales II-6
Table 2: US Breast Augmentation Procedure by Breast Implant
Type: 2007, 2009, 2011 (includes corresponding Graph/Chart) II-6
Brides-to-be: The New Target Audience II-7
Breasts: Size Does Matter! II-7
Umbilicoplasty - Making the Belly Button Attractive II-7
Men - The Fast Emerging Target Market II-7
Enhanced Safety Drives Cosmetic Surgery Demand II-8
Liposuction for New Treatment Areas II-8
Middle-Aged Men Opt for Cosmetic Surgery II-8
Baby Boomers Prefer Facelifts to Facial Rejuvenation II-8
Baby Boomers Keen On Lifts II-8
MACS Lift: A Novel Long-Lasting, Less-Painful Facelift II-9
Youngsters, Seniors Crossroads Over Cosmetic Surgery II-9
Cosmetic Eye Rejuvenation Gains Popularity II-9
Americans Turn Cosmetic Surgeon Savvy II-9
Breast Augmentation Witnesses Slowdown II-9
The Allergan, Mentor Breast Implant Battle Continues II-10
Mentor's Acquisition by Johnson & Johnson, A Milestone in the
Breast Implant Market II-10
Table 3: Breast Implants Market - Percentage Share Breakdown
by Allergan and Mentor: 2010 (includes corresponding
Graph/Chart) II-10
Table 4: Breast Implants Market - Percentage Share Breakdown
by Allergan and Mentor for Saline Implants and Silicone Gel
Implants: 2010 (includes corresponding Graph/Chart) II-11
Juvederm Ultra Ousts Restylane II-11
Table 5: US Dermal Fillers Market: Percentage Share
Breakdown by Restylane, Perlane, Restylane Fine Line,
Hylaform, Captique, Collagen, Juvederm Ultra, Juvederm Ultra
Plus, Juvederm 30, Sculptra, Radiesse, Prevelle Silk,
Puragen, Glymatrix Collagen, and Others: 2006-2010 (includes
corresponding Graph/Chart) II-12
Market Leaders II-13
Table 6: US Cosmetic Surgery Products Market - Percentage
Share Breakdown by Allergan, Mentor, Medicis, and Others:
2010 (includes corresponding Graph/Chart) II-13
Table 7: US Dermal Filler Market - Percentage Share
Breakdown by Medicis, Allergan, Dermik, BioForm Medical,
Artes Medical, Mentor Corp. and J&J: 2006-2010 (includes
corresponding Graph/Chart) II-14
Table 8: US Botulinum Toxin Type A Market - Percentage Share
Breakdown by Botox Cosmetic and Reloxin: 2007-2010 (includes
corresponding Graph/Chart) II-15
Table 9: US Cosmetic Lasers Market (2010) - Percentage Share
Breakdown by Revenue for Candela Corp., Syneron, Cynosure
Inc., Palomar Medical Technologies, Lumenis Ltd., Cutera
Inc., Alma, Reliant Technologies, Thermage, Ultrashape and
Laserscope (includes corresponding Graph/Chart) II-16
1c. THE YEAR 2011 IN PERSPECTIVE II-17
Quick Facts II-17
The Cosmetic Surgery Market in 2011 II-17
Table 10: Total Number of Cosmetic Procedures by Type in the
US: Surgical and Non-Surgical Procedures for the Years 2007
through 2011 (includes corresponding Graph/Chart) II-18
Table 11: Total Number of Cosmetic Procedures by Gender in
the US: 2011 (includes corresponding Graph/Chart) II-18
Table 12: Total Number of Cosmetic Procedures by Gender in
the US: 2007, 2008 and 2009 (includes corresponding
Graph/Chart) II-19
Market by Location II-20
Table 13: Percentage Share of Cosmetic Procedures by
Location in the US: 2011 (includes corresponding
Graph/Chart) II-20
Market by Age Group II-20
Table 14: Cosmetic Procedures by Age Group in the US:
2011(includes corresponding Graph/Chart) II-20
Table 15: Total Number of Surgical Cosmetic Procedures by
Age Group in the US: 2011 II-21
Table 16: Total Number of Non-surgical Cosmetic Procedures
by Age Group in the US: 2011 II-22
Market by Gender II-22
Surgical Procedures for Women II-22
Table 17: Ten Leading Surgical Cosmetic Procedures for
Women in the US: 2011 (includes corresponding Graph/Chart) II-23
Table 18: Ten Leading Surgical Cosmetic Procedures for
Women in the US: 2008 and 2009 (includes corresponding
Graph/Chart) II-24
Surgical Procedures for Men II-25
Table 19: Ten Leading Surgical Cosmetic Procedures for Men
in the US Non-Surgical Procedures: 2011 (includes
corresponding Graph/Chart) II-25
Table 20: Ten Leading Surgical Cosmetic Procedures for Men
in the US: 2008 and 2009 (includes corresponding
Graph/Chart) II-26
Non-Surgical Procedures for Women II-27
Table 21: Ten Leading Non-surgical Cosmetic Procedures for
Women in the US: 2011 (includes corresponding Graph/Chart) II-27
Table 22: Ten Leading Non-surgical Cosmetic Procedures for
Women in the US: 2008 and 2009 (includes corresponding
Graph/Chart) II-28
Non-Surgical Procedures for Men II-29
Table 23: Ten Leading Non-Surgical Cosmetic Procedures for
Men in the US: 2011(includes corresponding Graph/Chart) II-29
Table 24: Ten Leading Non-Surgical Cosmetic Procedures for
Men in the US: 2009 (includes corresponding Graph/Chart) II-30
Table 25: Ten Leading Non-Surgical Cosmetic Procedures for
Men in the US: 2008 (includes corresponding Graph/Chart) II-31
Market by Ethnicity II-31
Table 26: Percentage Share of Cosmetic Procedures by
Race/Ethnicity in the US: 2007,2009 & 2010 (includes
corresponding Graph/Chart) II-32
Historic Review (2007-2001) II-33
Table 27: Total Number of Cosmetic Surgical Procedures:
2007-2001 (includes corresponding Graph/Chart) II-33
Table 28: Total Number of Cosmetic Non-surgical Procedures:
2007-2001 (includes corresponding Graph/Chart) II-34
1d. COSMETIC PROCEDURES: AN OVERVIEW II-35
Surgical Procedures II-35
Table 29: Total Number of Cosmetic Surgical Procedures in the
US: 2010 and 2011 II-35
Table 30: Total Number of Cosmetic Surgical Procedures in the
US: 2009, 2008 and 1997 (includes corresponding Graph/Chart) II-36
Liposuction (Lipoplasty) II-37
Liposuction Technique Types II-37
Dry Technique II-37
Wet Technique II-37
Superwet Technique II-37
Tumescent Technique II-37
Breast Procedures II-37
Breast Augmentation II-38
Risks and Side Effects II-38
Life and Associated Costs II-39
Breast Reduction II-39
Female Breast Reduction II-39
Male Breast Reduction (Gynecomastia) II-40
Breast Lift II-40
Breast Augmentation Revision II-41
Risks and Side Effects II-41
Blepharoplasty (Cosmetic Eyelid Surgery) II-41
Eyelid Surgery Types II-42
Transconjunctival Blepharoplasty II-42
Upper Blepharoplasty II-42
Lower Blepharoplasty II-42
Others II-43
Risks and Adverse Effects II-43
Abdominoplasty (Tummy Tuck) II-43
Risks and Adverse Effects II-43
Rhinoplasty (Nose Reshaping) II-43
Rhinoplasty Types II-44
Risks and Adverse Effects II-44
Rhytidectomy (Facelift) II-44
Risks and Adverse Effects II-45
Otoplasty (Cosmetic Ear Surgery) II-45
Risks and Adverse Effects II-45
Hair Transplantation II-45
Hair Transplant Types II-46
Follicular Unit Extraction II-46
Mini & Micro-grafting II-46
Laser Grafting II-46
Punch Grafts II-46
Micro-Hair Transplant II-46
Hair Transplant Costs II-47
Gluteoplasty (Buttock Surgery) II-47
Buttock Surgery Types II-47
Contour Irregularity II-47
Buttock Reduction II-48
Buttock Augmentation II-48
Buttock Lift II-48
Risks and Side Effects II-49
Other Surgical Procedures II-49
Chin Surgery II-49
Chin Augmentation II-49
Risks and Side Effects II-49
Chin Reduction II-50
Double Chin Surgery II-50
Lip Surgery II-50
Lip Augmentation II-50
Lip Reduction II-50
Risks and Side Effects II-51
Lip Lift II-51
Cheek Augmentation II-51
Risks and Side Effects II-51
Forehead Lift II-52
Brow Lift II-52
Thigh Lift II-52
Lower-Jaw Surgery II-52
Non-Surgical Procedures II-52
Table 31: Total Number of Cosmetic Non-surgical Procedures
in the US: 2010, 2011 and 1997 II-53
Table 32: Total Number of Cosmetic Non-surgical Procedures
in the US: 2009, 2008 and 1997 II-54
Injections II-54
Botulinum Toxin Type A II-54
Botox Cosmetic II-55
Eligibility II-55
Risks and Side Effects II-55
Reloxin II-56
Puretox II-56
Dermal Fillers II-56
Synthetic Vs. Natural II-56
Permanent Vs. Temporary II-56
Dermal Filler Types II-57
Collagen II-57
Risks and Side Effects II-57
Hyaluronic Acid II-57
Risks and Side Effects II-58
Calcium Hydroxylapatite II-58
Risks and Side Effects II-58
Autologous Fat II-58
Risks and Side Effects II-59
Poly-L-Lactic Acid (Polyactate) II-59
Risks and Side Effects II-59
Polymethyl Methacrylate II-59
Risks and Side Effects II-60
Sclerotherapy II-60
Risks and Side Effects II-60
Lasers II-60
Laser Skin Resurfacing II-61
Risks and Side Effects II-61
Laser Hair Removal II-61
Eligibility II-62
Risks and Side Effects II-62
Laser Treatment of Leg Veins II-62
Risks and Side Effects II-63
Other Laser Treatments II-63
Laser Dermabrasion II-63
Risks and Side Effects II-63
Laser Facelift II-64
Laser Hair Replacement II-64
Laser Hair Transplantation II-64
Risks and Side Effects II-64
Laser Blepharoplasty II-64
Skin Resurfacing II-65
Chemical Peels II-65
Chemical Peels Types II-65
Mild Chemical Peel II-65
Risks and Side Effects II-66
Medium Chemical Peel II-66
Risks and Side Effects II-66
Deep Chemical Peel II-66
Risks and Side Effects II-66
Dermabrasion II-66
Risks and Side Effects II-66
Standard Dermabrasion II-67
Risks and Side Effects II-67
Microdermabrasion II-67
Risks and Side Effects II-67
Photo-rejuvenation II-67
Risks and Side Effects II-68
Non-surgical Facelifts II-68
Feather Lift II-69
Risks and Side Effects II-69
Thermal Facelift II-69
Endoscopic Facelift II-69
Non-surgical Eyelift II-70
Non-surgical Chin Augmentation II-70
Non-surgical Lip Augmentation II-70
Other Non-surgical Procedures II-71
IPL Hair Removal II-71
IPL Tattoo Removal II-71
LipoDissolve II-71
VelaShape II-71
Thermage II-72
Accent II-72
1e. COSMETIC SURGERY PRODUCTS: OVERVIEW II-73
Equipment II-73
Liposuction Equipment and Systems II-73
Vaser II-73
SmartLipo II-73
CoolLipo II-74
LipoLite II-74
Lasers II-74
Laser Types II-74
CO2 Laser (Skin Resurfacing) II-74
Erbium Laser (Skin Resurfacing) II-75
Erbium:YAG Laser (Skin Resurfacing) II-75
Fraxel Laser (Skin Resurfacing and Rejuvenation) II-75
N-Lite Laser (Photo-rejuvenation) II-75
Smooth-Beam (Photo-rejuvenation/ Acne / Acne Scars) II-76
Cool-Touch (Photo-rejuvenation) II-76
CoolTouch III (Photo-rejuvenation) II-76
Ruby Laser (Hair Removal) II-76
Alexandrite Laser (Hair Removal) II-77
Diode Laser (Hair Removal) II-77
Nd: YAG Laser (Hair Removal) II-77
Q-switched Ruby Laser (Tattoo Removal) II-77
Q-switched Alexandrite Laser (Tattoo Removal) II-77
Q-switched Nd:YAG Laser (Tattoo Removal) II-77
Light-based Systems II-77
Other Equipment II-78
Injectables II-78
Botulinum Toxin Type A II-78
Dermal Fillers II-78
Collagen Fillers II-79
Zyderm and Zyplast (bovine) II-79
Cosmoderm and Cosmoplast (human) II-79
Evolence (porcine) II-79
Fibrel II-80
Fascian II-80
Hyaluronic Acid Fillers II-80
List of Approved Hyaluronic Acid Dermal Fillers II-80
Hylaform II-81
Restylane II-81
Perlane II-81
Juvederm II-82
Elevess II-82
Captique II-82
Prevelle Silk II-82
Prevelle Plus II-82
Puragen II-83
Puragen Plus II-83
Restylane SubQ II-83
Restylane Touch II-83
Calcium Hydroxylapatite Fillers II-83
Radiesse II-83
Poly-L-Lactic Acid Fillers II-84
Sculptra II-84
Polymethyl Methacrylate Fillers II-84
ArteFill II-84
Silicone Fillers II-84
SilSkin II-84
Silikon 1000 II-85
Implants II-85
Breast Implants II-85
Saline Implants II-85
Silicone Implants II-85
Facial Implants II-86
Goretex Implants (Lips and Chin) II-86
SoftForm Implants (Lips) II-87
Ultrasoft Implants (Lips) II-87
Silicone Implants (Chin) II-87
Others II-87
1f. PRODUCT INTRODUCTIONS II-88
Palomar Medical Technologies to Introduce Home Use Laser II-88
Eleme Medical Introduces SmoothShapes XV II-88
Merz Pharma to Launch Xeomin in the US II-88
Allergan Receives US FDA Clearance for JUVEDERM XC II-88
Medicis Gains FDA Approval for Perlane-L and Restylane-L
Dermal Fillers II-89
Cytori Obtains FDA Clearance for PureGraft II-89
MYA Cosmetic Surgery Launches Advanced Laser Lipolysis II-89
The Harley Medical Group Introduces Holy Grail Cosmetic Laser
Treatment II-90
Johnson & Johnson to Introduce Mentor Products in India II-90
TRIA Beauty Unveils TRIA LHRS in Korea II-90
Medical Alliance Services Unveils Custom Acoustic Liposuction
System II-90
Axis Three Launches Advanced 3D Software Tool II-91
Keller Medical Launches KellerFunnelTM Silicone Gel Implant
Delivery Device II-91
Personique Surgery Center Launches Perma Facial ImplantTM II-91
Coapt Systems Introduces Hydrelle Dermal Filler II-92
SKINovative® Houston Offers Zerona Laser Treatment II-92
Cosmetic Enhancement Center Extends Cosmetic Treatment Range
with Lumenis® UltraPulse CO2 Fractional Laser Treatment II-92
Ideal Implant Develops Hybrid Saline Breast Implant II-93
Medicis Gains FDA Approval for Reloxin II-93
BioForm Obtains FDA Approval to Mix Lidocaine with RADIESSE®
Dermal Filler II-93
BioElectronics Seeks FDA Approval for Allay Period Relief Patch II-93
Sanofi-aventis Receives FDA Approval for Sculptra®Aesthetic Acid II-94
Allergan Launches Advanced Dermal Hyaluronic Acid Dermal Fillers II-94
1g. PRODUCT INTRODUCTIONS/APPROVALS - A HISTORIC PERSPECTIVE BUILDER II-95
Cynosure Launches Affirm CO2 II-95
HOYA ConBio Introduces V-Raser for Vascular Lesions II-95
Cynosure Launches Smartlipo MPX Workstation II-95
CoolTouch Introduces CoolBlue Duet Handpiece II-95
CoolTouch Launches CoolLipo Laser System II-96
Genesis Biosystems Launches AccelaFuze Skin Rejuvenation System II-96
TRIA Beauty Rolls Out TRIA Personal Hair Removal System II-96
Sciton Launches ProFractional-XC Dual-Mode Fractional Laser II-97
Image4Life Launches Laser Hair Removal Services II-97
Dr. Hilton Becker Unveils Spectra Adjustable Gel Implant II-97
Photo Therapeutics Secures FDA Approval for Omnilux New-U II-98
Mentor Secures FDA Approval for HA Dermal Filler II-98
Ipsen and Medicis Announces Reloxin BLA Acceptance by FDA II-98
Ortho-McNeil-Janssen Announces FDA Approval for Evolence II-98
Evera Medical Secures FDA Approval for FulFil Lip IDE Application II-98
Allergan Launches Two Next-Generation Dermal Filler Lines II-99
Cynosure Introduces New 18-watt Smartlipo LaserBody Sculpting
Workstation II-99
Cynosure Introduces New 10-watt Smartlipo LaserBodySculpting
Workstation II-99
Lumenis Launches Bridge Therapy Laser Skin Treatment II-99
Cynosure Introduces New Nd:YAG Laser for Affirm Workstation II-100
Cynosure Introduces Smartlipo LaserBodySculpting Procedure II-100
Genesis Biosystems Launches New Regenlite Laser System II-100
Hoya ConBio Launches AimLite Aiming Beam II-101
Hoya ConBio Introduces New PurpuraLite Laser Device II-101
Thermage Introduces New ThermaTip STC II-101
Thermage Launches New ThermaTip DC II-101
Thermage Launches Lips by Thermage Non-Invasive Skin
Tightening Procedure II-102
Rhytec Launches New Plasma Treatment II-102
Candela Expands Product Portfolio II-102
Cynosure Launches Smartlipo with Laser Body Sculpting II-102
Clinicares to Launch Micro Roller II-102
Cardinal Health Launches Presource® Standard Cosmetic-Surgery
Packs II-103
Palomar Medical to Introduce Laser-Assisted Lipolysis Platform II-103
Radiancy Introduces Mistral Light-based System II-103
SmartLipo™ Launched in Canadian Market II-103
Reliant Technologies Launches Fraxel Re:pair® Laser System in
Canada II-104
Cytori to Launch Fast-track Breast Enlargement Procedure in
Europe II-104
Sanofi-Aventis Canada Launches Sculptra in Canada II-105
1h. RECENT INDUSTRY ACTIVITY II-106
Cutera Inc. Acquires the Aesthetic Business of IRIDEX II-106
Valeant Pharmaceuticals Acquires Dermik II-106
Allergan Acquires Reconstructive and Cosmetic Surgery Unit of
Serica II-106
MicroAire Surgical Instruments Purchases Endotine® Products
from Coapt Systems II-106
Merz Pharma Group Acquires BioForm Medical II-107
Syneron Medical Merges with Candela II-107
Cosmetic Harmony Launches Clinic-cum-Hotel-cum-Spa II-108
General Healthcare Group Takes Over Minority Stake in
Transform Holdings II-108
SurgiCare Acquires Plastic Surgery Partners II-108
Ache Laboratories Inks Licensing Contract with Prollenium
Medical Technologies II-108
Sanofi-aventis Canada Signs Definitive Agreement with Canderm
Pharma II-109
Johnson & Johnson Acquires Mentor Corporation II-109
Medicis Ink License Deal with Revance II-109
Thermage Acquires Reliant Technologies II-109
Ivivi Technologies Inks Definitive Agreement with Grupo Venta
Internacional II-110
Cutera Enters into Strategic Alliance with Obagi and Sound
Surgical II-110
Bausch & Lomb and Karl Storz Ink Agreement II-110
Thermage Changes Name to Solta Medical II-111
BB Beauty and Beyond to Provide Korean Cosmetic Surgery II-111
Rodial Enters into Partnership with Perfect Enhancement II-111
The Hospital Group Acquires Controlling Stake in Mills & Mills
Medical Group II-111
Biocompatibles International Receives CE Mark Approval for
Cosmetic Dermal Filler Bead II-112
1i. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-113
IRIDEX Acquires Aesthetics Business of Laserscope II-113
Medicis Acquires LipoSonix II-113
BioForm Takes Over Advanced Cosmetic II-113
BioForm Acquires Advanced Cosmetic's Nerve Ablation Technology II-113
Palomar and Astron Sign Distribution Deal for Aesthetic
Imaging Products II-114
Palomar Signs Agreement with P&G II-114
PhotoMedex Signs Agreement to Take Over Photo Therapeutics II-114
Thermage Acquires Reliant II-115
Laser Cosmetics Divests Stake to Indiaco II-115
Katzen Launches New Cosmetic Division, AESTHETICS by Katzen II-115
Mentor Acquires Perouse Plastie II-115
Anika and Canderm Pharma Sign Agreement II-116
Palomar Inks Agreement with Q-MED II-116
Dr Reddys Enters into Distribution Agreement with Cosmederm II-116
Q-Med and Medy-Tox Terminate Collaboration Agreement II-117
Park West Clinic Group to Start Two New Clinics in Ireland II-117
Sientra Announces Acquisition of Silimed Assets II-117
Cynosure Signs Distribution Pact with Eclipse for Smartlipo™
System II-117
Hoya ConBio and Eclipse Sign Exclusive Distribution Pact for
Aesthetic Lasers II-118
Heritage Worldwide to Expand Production Capacity II-118
Gillette and Palomar Revise Agreement to Introduce Hair-
Removal Device II-118
Allergan Receives FDA Approval for Juvederm Label Extensions II-118
Cynosure Secures Approval for Smartlipo LaserBodySculpting
Workstation II-119
Cynosure Secures Approval for Affirm™ Laser System II-119
Medicis Secures FDA Approval for Perlane II-119
Sciton Secures FDA Approval for ProLipo™ Laser-assisted System II-119
BioForm Medical Secures FDA Approval for Radiesse® II-120
Cutera Receives FDA and CE Mark Approval for Pearl II-120
3i Group Acquires Ultralase II-120
Ipsen Strikes Deal with Galderma II-120
Anika Receives CE Mark Approval for Elevess II-120
Cynosure Secures Approval to Market Elite in China II-121
Palomar Opens Office in the Netherlands II-121
John Ryan Establishes Cosmetic Surgery Business II-121
1j. FOCUS ON SELECT PLAYERS II-122
Allergan, Inc. (US) II-122
Anika Therapeutics, Inc. (US) II-122
Merz Aesthetics (Formerly BioForm Medical Inc.) (US) II-122
Candela Corporation (US) II-122
Cutera Inc. (US) II-123
Cynosure, Inc. (US) II-123
DermaMed Solutions (US) II-123
Valeant Pharmaceuticals International, Inc. (US) II-124
ExcellaDerm Corporation (US) II-124
Genesis Biosystems Inc. (US) II-124
Johnson & Johnson (US) II-124
Mentor Corp. (US) II-125
Lumenis Ltd. (Israel) II-125
Medicis Pharmaceutical Corporation (US) II-125
Palomar Medical Technologies, Inc. (US) II-126
Q-Med AB (Sweden) II-126
Solta Medical, Inc. (US) II-126
Suneva Medical, Inc. (US) II-127
1k. US MARKET ANALYTICS II-128
Table 33: The US Recent Past, Current & Future Analysis for
Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Abdominoplasty, Blepharoplasty, Facelift,
Liposuction, Rhinoplasty, and Others), and Non-surgical
(Botox, Dermal Fillers, Laser Hair Removal, Laser Skin
Resurfacing, Chemical Peel, Microdermabrasion, and Others)
Markets Independently Analyzed with Annual Demand Figures in
US$ Million for Years 2009 through 2017(includes corresponding
Graph/Chart) II-128
Table 34: The US Historic Review for Cosmetic Procedures by
Procedure Type - Surgical (Breast Augmentation,
Abdominoplasty, Blepharoplasty, Facelift, Liposuction,
Rhinoplasty, and Others), and Non-surgical (Botox, Dermal
Fillers, Laser Hair Removal, Laser Skin Resurfacing, Chemical
Peel, Microdermabrasion, and Others) Markets Independently
Analyzed with Annual Demand in US$ Million for Years 2003
through 2008 (includes corresponding Graph/Chart) II-129
Table 35: The US 15-Year Perspective for Cosmetic Procedures
by Procedure Type - Percentage Breakdown of Demand for
Surgical (Breast Augmentation, Abdominoplasty, Blepharoplasty,
Facelift, Liposuction, Rhinoplasty, and Others), and
Non-surgical (Botox, Dermal Fillers, Laser Hair Removal, Laser
Skin Resurfacing, Chemical Peel, Microdermabrasion, and
Others) Markets for Years 2003, 2011 & 2017(includes
corresponding Graph/Chart) II-130
Table 36: The US Recent Past, Current & Future Analysis for
Cosmetic Surgery Products by Product Segment - Equipment
(Lasers, Microdermabrators and Other Equipment), Injectables
(Botulinum Toxin Type A, Dermal Fillers, and Other
Injectables), Implants (Breast Implants and Other Implants),
and Other Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017(includes
corresponding Graph/Chart) II-131
Table 37: The US Historic Review for Cosmetic Surgery Products
by Product Segment - Equipment (Lasers, Microdermabrators and
Other Equipment), Injectables (Botulinum Toxin Type A, Dermal
Fillers, and Other Injectables), Implants (Breast Implants and
Other Implants), and Other Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) II-132
Table 38: The US 15-Year Perspective for Cosmetic Surgery
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Equipment (Lasers, Microdermabrators and Other
Equipment), Injectables (Botulinum Toxin Type A, Dermal
Fillers, and Other Injectables), Implants (Breast Implants and
Other Implants), and Other Markets for Years 2003, 2011 & 2017
(includes corresponding Graph/Chart) II-133
2. REST OF WORLD II-134
2a. EUROPE II-134
A.Market Analysis II-134
Highlights of the European Cosmetic Surgery Market II-134
Recession and Beyond II-134
B.Market Analytics II-135
Table 39: European Recent Past, Current & Future Analysis
for Cosmetic Procedures by Geographic Region - France,
Germany, Italy, UK, Spain, and Rest of Europe Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2009 through 2017 (includes corresponding
Graph/Chart) II-135
Table 40: European Historic Review for Cosmetic Procedures
by Geographic Region - France, Germany, Italy, UK, Spain,
and Rest of Europe Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-136
Table 41: European 15-Year Perspective for Cosmetic
Procedures by Geographic Region - Percentage Breakdown of
Annual Revenues for France, Germany, Italy, UK, Spain, and
Rest of European Markets for Years 2003, 2011 & 2017
(includes corresponding Graph/Chart) II-137
Table 42: European Recent Past, Current & Future Analysis
for Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-138
Table 43: European Historic Review for Cosmetic Procedures
by Procedure Type - Surgical (Breast Augmentation,
Liposuction, Blepharoplasty, and Rhinoplasty), and
Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-139
Table 44: European 15-Year Perspective for Cosmetic
Procedures by Procedure Type - Percentage Breakdown of
Annual Revenues for Surgical (Breast Augmentation,
Liposuction, Blepharoplasty, and Rhinoplasty), and
Non-Surgical Markets for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-140
2Aa. FRANCE II-141
Market Analysis II-141
Table 45: French Recent Past, Current & Future Analysis for
Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-142
Table 46: French Historic Review for Cosmetic Procedures by
Procedure Type - Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-143
Table 47: French 15-Year Perspective for Cosmetic Procedures
by Procedure Type - Percentage Breakdown of Annual Revenues
for Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-144
2Ab. GERMANY II-145
A.Market Analysis II-145
Highlights of the German Cosmetic Surgery Market: II-145
Cost Advantage for British Patients II-145
B.Market Analytics II-146
Table 48: German Recent Past, Current & Future Analysis for
Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-146
Table 49: German Historic Review for Cosmetic Procedures by
Procedure Type - Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-147
Table 50: German 15-Year Perspective for Cosmetic Procedures
by Procedure Type - Percentage Breakdown of Annual Revenues
for Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-148
2Ac. ITALY II-149
Market Analysis II-149
Table 51: Italian Recent Past, Current & Future Analysis for
Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-150
Table 52: Italian Historic Review for Cosmetic Procedures by
Procedure Type - Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-151
Table 53: Italian 15-Year Perspective for Cosmetic
Procedures by Procedure Type - Percentage Breakdown of
Annual Revenues for Surgical (Breast Augmentation,
Liposuction, Blepharoplasty, and Rhinoplasty), and
Non-Surgical Markets for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-152
2Ad. THE UNITED KINGDOM II-153
A.Market Analysis II-153
Cosmetic Surgery Industry Defies Recession II-153
Highlights of the UK Cosmetic Surgery Market: II-153
Cosmetic Surgery: Consumer Perception or Created Perception! II-154
Market Outlook II-154
UK Spending on Cosmetic Surgery II-155
Leading Cosmetic Surgery Procedures II-155
Table 54: Five Leading Cosmetic Surgical Procedures in the
UK: 2011 (includes corresponding Graph/Chart) II-156
Women Dominate, Men Drive the Market II-156
Table 55: Cosmetic Surgical Procedures Market by Gender in
the UK: 2011 (includes corresponding Graph/Chart) II-157
Table 56: Cosmetic Surgical Procedures Market by Gender in
the UK: 2008 & 2009 (includes corresponding Graph/Chart) II-157
Table 57: Five Leading Cosmetic Surgical Procedures for
Women in the UK: 2011 (includes corresponding Graph/Chart) II-158
Table 58: Five Leading Cosmetic Surgical Procedures for
Men in the UK: 2011 (includes corresponding Graph/Chart) II-158
Table 59: Five Leading Cosmetic Surgical Procedures for
Women in the UK: 2008 & 2009 (includes corresponding
Graph/Chart) II-159
Table 60: Five Leading Cosmetic Surgical Procedures for
Men in the UK: 2008 & 2009 (includes corresponding
Graph/Chart) II-159
Market Trends II-160
Cosmetic Surgery Demand on the Roll, Prices Plunge in 2009 II-160
Surgical Procedure Abroad Becomes Dearer II-160
Cosmetic Surgery Finds Appeal with Politicians and Businessmen II-160
Liposuction Gains Popularity Among Brits II-160
Cosmetic Surgery for Elderly on the Rise in UK II-161
Cosmetic Surgery for Partners - The New Fad II-161
Marketing Tactics - A Cause of Concern II-161
Male Breast Reduction Demand Spirals II-161
Browlift Surgery Gains Popularity II-162
Men Find Appeal in Cosmetic Surgery II-162
Celebrity Profiles Drive Demand for Chin Enhancements II-162
Baby Botox for More Natural Look II-162
B.Market Analytics II-163
Table 61: The UK Recent Past, Current & Future Analysis for
Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-163
Table 62: The UK Historic Review for Cosmetic Procedures by
Procedure Type - Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-164
Table 63: The UK 15-Year Perspective for Cosmetic Procedures
by Procedure Type - Percentage Breakdown of Annual Revenues
for Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-165
2Ae. SPAIN II-166
A.Market Analysis II-166
Highlights of the Spanish Cosmetic Surgery Market: II-166
Spain: Holds Great Potential for Cosmetic Surgery II-166
Cosmetic Surgery for Minors Grows II-167
B.Market Analytics II-168
Table 64: Spanish Recent Past, Current & Future Analysis for
Cosmetic Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-168
Table 65: Spanish Historic Review for Cosmetic Procedures by
Procedure Type - Surgical (Breast Augmentation, Liposuction,
Blepharoplasty, and Rhinoplasty), and Non-Surgical Markets
Independently Analyzed with Annual Revenues in US$ Million
for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-169
Table 66: Spanish 15-Year Perspective for Cosmetic
Procedures by Procedure Type - Percentage Breakdown of
Annual Revenues for Surgical (Breast Augmentation,
Liposuction, Blepharoplasty, and Rhinoplasty), and
Non-Surgical Markets for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-170
2Af. REST OF EUROPE II-171
A.Market Analysis II-171
Highlights of the Rest of Europe Cosmetic Surgery Market: II-171
Focus on Select Regions II-171
Ireland II-171
Irish Cosmetic Surgery Market Weathers Recession II-171
Denmark II-172
Cosmetic Surgery Market in Denmark II-172
Interest in Cosmetic Surgeries Burdens Public Healthcare
System II-172
High Costs, Long Waiting Periods, Encourage Medical Travel
to Other Nations II-172
India - The Potential Danish Favorite for Medical Travel II-172
Czech Republic II-173
Highlights of the Czech Cosmetic Surgery Market II-173
B.Market Analytics II-174
Table 67: Rest of European Recent Past, Current & Future
Analysis for Cosmetic Procedures by Procedure Type -
Surgical (Breast Augmentation, Liposuction, Blepharoplasty,
and Rhinoplasty), and Non-Surgical Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2009
through 2017 (includes corresponding Graph/Chart) II-174
Table 68: Rest of European Historic Review for Cosmetic
Procedures by Procedure Type - Surgical (Breast
Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty),
and Non-Surgical Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2003 through 2008
(includes corresponding Graph/Chart) II-175
Table 69: Rest of European 15-Year Perspective for Cosmetic
Procedures by Procedure Type - Percentage Breakdown of
Annual Revenues for Surgical (Breast Augmentation,
Liposuction, Blepharoplasty, and Rhinoplasty), and
Non-Surgical Markets for Years 2003, 2011 & 2017 (includes
corresponding Graph/Chart) II-176
2b. ASIA-PACIFIC II-177
Australia II-177
Spending On Cosmetic Procedures Remains Unabated Amid Recession II-177
Men to Drive the Cosmetic Surgery Market II-177
India II-178
The Indian Cosmetic Surgery Market II-178
Table 70: Indian Cosmetic Surgery Market by Procedure Type
(Revenue in US$ Million): 2011 (includes corresponding
Graph/Chart) II-178
Table 71: Indian Cosmetic Surgery Market by Procedure Type -
Market Share Breakdown by Number of Surgical and
Non-surgical Procedures in 2011 (includes corresponding
Graph/Chart) II-179
A Destination of Choice for Foreign Patients II-179
Indian Women Get Breast Implant Friendly II-179
Men - The New Takers for Cosmetic Surgery II-180
South Korea II-180
South Korea - The New Asian Medical Tourism Center II-180
China II-180
The Chinese Cosmetic Surgery Market II-180
Taiwan II-181
Thailand II-181
Cosmetic Surgery Industry Outlives Recession II-181
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 78 (including Divisions/Subsidiaries - 88)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 53
Canada 3
Europe 19
France 3
Germany 5
The United Kingdom 5
Italy 2
Rest of Europe 4
Asia-Pacific (Excluding Japan) 11
Middle East 2
------------------------------------------
The cosmetic surgery market is back on track in the US after witnessing declining margins, triggered by the global economic recession. The youth focused-American society, growing popularity of non-surgical procedures and continued interest to enhance their physical appearance, continues to drive the demand for cosmetic procedures and cosmetic surgery products in the region. Low cost treatment continues to remain popular among Americans. This factor holds true, particularly for injectable dermal fillers, wrinkle fillers, laser-based treatment and other less expensive cosmetic procedures. In addition, the alarming rate of overweight and obese people bodes well for procedures aimed at body contouring. Breast implants represent a key segment of the US cosmetic surgery products market, which is portended to continue its run, despite the financial crisis that vexed the US economy in the recent years. With a major advantage being the non-availability of any non-invasive alternative, the demand for implants is forecast to grow steadily. Television talk shows, reality shows, and online resources are additionally enhancing public awareness of breast implants, including silicone and saline implants. Celebrities, and cosmetic surgeons and clinics, also stand as strong factors fueling the procedural volumes. Future growth in the US breast implants market is expected to stem from anatomical breast implants, which are soaring in popularity, and by the approval of improved, more solid consistency silicone versions that would carry relatively lesser risk of rupture or leakage.
Non-surgical procedures account for a lion’s share in terms of number of procedures in the US, as stated by the new market research report on Cosmetic Procedures and Products. Though non-surgical procedures are performed in rather large numbers and are preferable due to their non-invasive nature and quick treatment times, the surgical procedures however contribute the lion's share of the cosmetic procedures and products market. Breast augmentation and the injectable Botulinum Toxin Type A (including Botox and Dysport) were the leading surgical and non-surgical cosmetic procedures performed in the year 2011, respectively. Among non-surgical treatment, demand for botox, dermal fillers (especially HA fillers), and microdermabrasion would continue to drive market growth. With more investigational non-invasive fat removal procedures, including the Smartlipo laser liposuction and cryolipolysis, expected to gain approval in the coming years, the market for non-surgical procedures is set to grow and expand further.
In terms of cosmetic surgery products, injectables represent the largest and fastest growing segment of the US cosmetic surgery products market. Key growth drivers include the non-invasive nature of these products, faster outcome, no downtime, and convenience without significant lifestyle changes often associated with surgical procedures. With more hyaluronic acid fillers expected to gain approval in the coming years, the injectables market is set to grow and expand. Increased product availability, strong marketing efforts, value-for-money, more FDA approvals, and expanding consumer interest and awareness, would continue to act as a growth engine for this segment.
In Europe, cosmetic surgery procedures account for the largest revenue share of the overall cosmetic procedures market, while non-surgical techniques outdo in terms of number of procedures performed in a year. Demand for non-surgical cosmetic procedures is significantly high, due to their non-invasiveness, reduced or no recovery time, and minimal side effects. Advancements in laser technology pushes demand beyond conventional procedures to new ones, such as laser liposuction. The UK is not only the largest market for cosmetic surgery procedures in Europe, but is also the fastest growing. Despite of turbulent economic conditions, the demand for cosmetic surgery remained unabated in the UK.
Global Industry Analysts ©
- Allergan, Inc. (USA)
- Allied Biomedical (USA)
- Alma Lasers (USA)
- Anika Therapeutics, Inc. (USA)
- Anthony Products, Inc. (USA)
- Asclepion Laser Technologies GmbH (Germany)
- Bal-Tech Medical (USA)
- Bioform Medical, Inc. (USA)
- Bioplate, Inc. (USA)
- Candela Corporation (USA)
- Cardinal Health, Inc. (USA)
- Changzhou Mingjiao Import and Export Corporation Ltd. (China)
- Cloverleaf Medical Ltd. (UK)
- CoolTouch, Inc. (USA)
- Cutera, Inc. (USA)
- Cynosure, Inc. (USA)
- Cytori Therapeutics (USA)
- Dali Hyaluronic Acid Co., Ltd. (China)
- Dectro International (France)
- Deka (France)
- Dermamed International, Inc. (USA)
- DermaMed Solutions LLC (USA)
- DPS Co., Ltd. (Hong Kong)
- Erchonia Medical, Inc. (USA)
- Erothitan Titanium Implants Ltd. (UK)
- Eurosurgical Ltd. (UK)
- Evera Medical, Inc. (USA)
- Excelladerm Corporation (USA)
- Fascia Biosystems LLC (USA)
- Focus Medical (USA)
- Genesis Biosystems, Inc. (USA)
- Genetic Instruments Pvt., Ltd. (India)
- Genzyme Corporation (USA)
- George Tiemann Co. (USA)
- Ghandour For Medical and Chemicals (Syria)
- Hangzhou Gallop Biological Products Co., Ltd. (China)
- HK Surgical (USA)
- Hoya ConBio™ (USA)
- Implantech (USA)
- Invotec International, Inc. (USA)
- Ipsen (France)
- IRIDEX Corporation (USA)
- Johnson & Johnson (USA)
- Katzen Eye Group (USA)
- Lasertight LLC (USA)
- Lica Srl (Italy)
- Lumenis Ltd. (Israel)
- Lumenis, Inc. (USA)
- Medco Manufacturing (USA)
- Medical Device Resource Corporation (USA)
- Medicis Pharmaceutical Corporation (USA)
- Medy-Tox, Inc. (South Korea)
- Mentor Corporation (USA)
- Mentor Medical Systems Canada, Inc. (Canada)
- Mentor Medical Systems Ltd. (UK)
- Mentor Medical Systems Australia Pty., Ltd. (Australia)
- Mentor Benelux BV (The Netherlands)
- Mentor Deutschland GmbH (Germany)
- Mentor Medical Italia Srl (Italy)
- Merz Pharma GmbH & Co. KGaA (Germany)
- Misonix, Inc. (USA)
- Nagor Ltd. (UK)
- Nanfeng Medical Sin&Tech., Ltd. (China)
- Nobel Biocare Holding AG (Switzerland)
- Nobel Biocare AB (Sweden)
- Nobel Biocare Canada, Inc. (Canada)
- Nobel Biocare USA LLC (USA)
- Oculo-Plastik, Inc. (Canada)
- Palomar Medical Technologies, Inc. (USA)
- Pharm Allergan GmbH (Germany)
- PMT Corporation (USA)
- Polytech Health & Aesthetics GmbH (Germany)
- Porex Surgical, Inc. (USA)
- Q-Med AB (Sweden)
- Radiancy, Inc. (USA)
- Sciton, Inc. (USA)
- Sientra, Inc. (USA)
- Sklar Instruments (USA)
- Solta Medical, Inc. (USA)
- Specialty Surgical Products (USA)
- Spectrum Designs Medical, Inc. (USA)
- Suneva Medical, Inc. (USA)
- Sunmax Biotechnology Co., Ltd. (Taiwan)
- Surgiform Technology Ltd. (USA)
- Syneron Medical Ltd. (Israel)
- TJ Bio Group (China)
- Tulip Biomed (USA)
- Valeant Pharmaceuticals International, Inc. (USA)
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
